Silanol terminated(14-18%diphenylsiloxane)-dimethylsiloxane copolymer, >95%, 100g

Ethyl 2-bromo-2-(4-bromophenyl)acetate, 97.0%, 10g

CRYPTOCHLOROGENIC ACID, 99%, 25mg

1-Hexyl-3-methyl-imidazolium-, hexafluorophosphate, min. 99%, 100 g, glass packaging

4-Bromo-3-(tert-butyl)-1H-pyrazole, 95.0%, 25g

EPINASTINE, 98%, 100mg

1-(Piperidin-4-yl)imidazolidin-2-one, 95.0%, 1g

Methyl 4-(2,2-diethoxyethoxy)benzoate, 95+%, 1g

1-tert-Butoxycarbonyl-1,2,4-triazole>97.0%(GC)5g

1-(4-Vinylbenzyl)-1H-imidazole, 95.0%, 10g

4-Fluoro-1H-indol-5-ol, 95.0%, 100mg

Methyl 1,2,3,4-tetrahydroquinoline-6-carboxylate, 95.0%, 1g

2,3,5-Tri-O-benzyl-D-ribono-1,4-lactone>98.0%(HPLC)5g